Founders Capital Management (Texas)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Founders Capital Management (Texas)'s GILD Position: Q2 2026 in Review
Founders Capital Management (Texas) held its Gilead Sciences (GILD) position steady in Q2 2026 at 512 shares worth $64.7K. The position accounts for 0.03% of the portfolio, ranked #133.
Founders Capital Management (Texas) first reported a position in GILD in Q1 2017 and has held it in 36 quarters since. The position peaked at $113K in Q1 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Founders Capital Management (Texas) held 512 shares of Gilead Sciences worth $64.7K as of Q2 2026.
- Founders Capital Management (Texas) left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.03% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #133 holding.
- Founders Capital Management (Texas) first reported a position in Gilead Sciences in Q1 2017 and has held it in 36 quarters since.
- Founders Capital Management (Texas)'s Gilead Sciences position peaked at $113K in Q1 2025.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.